UK health debates intensify as nursing union cuts ties with Israeli firm and fringe medicine tours Britain

Nursing union severs ties with Israeli drug firm over military links

Britain’s largest nursing union has taken a decisive step in its ethical procurement policy, cutting commercial ties with Teva UK, the British subsidiary of Israel’s largest pharmaceutical company. The Royal College of Nursing (RCN) confirmed this week that it had ended its partnership with Teva, which had included sponsorship of a forthcoming event on migraine and headache treatment at the union’s London headquarters.

The decision follows growing scrutiny of Teva’s corporate affiliations. The company, which supplies generic medicines to the NHS, has faced criticism for its historical ties to Israel’s defence sector. Teva’s parent company, Teva Pharmaceutical Industries, was founded in 1901 in Jerusalem and has maintained connections with the Israeli state, including supplying medical equipment to the Israel Defense Forces (IDF). While Teva UK operates independently, its corporate structure has drawn attention from advocacy groups calling for divestment from firms linked to Israel’s military actions in Gaza and the West Bank.

The RCN’s move reflects a broader shift in UK healthcare institutions grappling with the ethical implications of their supply chains. In a statement, the union emphasised that its decision was guided by "a commitment to human rights and ethical sourcing," though it stopped short of explicitly linking the action to the ongoing conflict in Gaza. The statement added that the RCN would "continue to review its commercial partnerships in line with its values and the expectations of its members."

The fallout has been swift. Pro-Palestinian campaign groups, including Medical Aid for Palestinians, have welcomed the decision, framing it as a victory for ethical healthcare procurement. Meanwhile, Teva UK has not publicly responded to the termination, though industry observers note that the company has faced similar challenges in other European markets, where calls for boycotts of Israeli-linked firms have gained traction.

For the RCN, the decision is not without risk. The union represents over 450,000 nurses and healthcare workers, many of whom rely on Teva’s affordable generic medicines in their daily practice. Some members have privately expressed concerns that the move could limit access to essential drugs, particularly amid ongoing NHS supply chain disruptions. The RCN has sought to reassure its members that the termination will not affect the availability of medicines, though it has not yet named alternative suppliers for the event sponsorship.

The controversy underscores the delicate balance UK healthcare institutions must strike between ethical procurement and practical delivery. As the NHS faces persistent drug shortages and financial strain, decisions like the RCN’s force a reckoning with how far ethical considerations should extend into commercial relationships—especially when those relationships underpin frontline care.

Banned Australian naturopath sparks UK debate over medical misinformation

A self-described "natural healer" who was barred from practising in Australia is set to embark on a UK speaking tour, reigniting debates over the regulation of alternative medicine and the spread of unproven health claims. Barbara O’Neill, a naturopath and nutritionist, has built an international following for her advocacy of "self-healing" through diet, herbal remedies, and lifestyle changes. Her teachings, which include the claim that cancer is a fungus treatable with bicarbonate of soda, have drawn sharp criticism from medical professionals and health authorities.

O’Neill’s upcoming UK and Ireland events have alarmed scientists and public health advocates. In 2019, the New South Wales Health Care Complaints Commission banned her from providing any health services in Australia, citing "unsubstantiated health claims" that posed "a risk to public health and safety." The commission’s ruling noted that O’Neill had "no formal qualifications in medicine, nursing, or nutrition" and that her advice "could lead to serious harm if followed."

Despite the ban, O’Neill has continued to lecture internationally, leveraging social media to reach audiences in the UK, US, and beyond. Her UK tour, which includes stops in London, Manchester, and Dublin, has been promoted through wellness influencers and alternative health networks. Tickets for the events, priced at up to £150 per person, promise attendees insights into "natural protocols for reversing chronic illness."

The controversy has exposed gaps in the UK’s regulation of alternative medicine practitioners. Unlike Australia, where health service providers must be registered and adhere to strict professional standards, the UK has no equivalent licensing system for naturopaths or nutritionists. While the Advertising Standards Authority (ASA) has previously ruled against O’Neill for making misleading health claims in online ads, her ability to host in-person events remains largely unchecked.

Public health experts have warned that O’Neill’s teachings could have dangerous consequences. Dr. David Robert Grimes, a cancer researcher and science communicator, described her claims as "not just wrong, but actively harmful." He added: "Promoting unproven remedies for serious conditions like cancer delays proper treatment and can cost lives. The fact that she is still able to tour and profit from these ideas is deeply concerning."

The UK’s National Health Service (NHS) has also weighed in, with a spokesperson stating that "there is no scientific evidence to support the claims made by Ms. O’Neill, and we urge the public to seek advice from qualified medical professionals." However, the NHS’s ability to counter such narratives is limited, particularly as alternative health influencers often frame conventional medicine as part of a broader "establishment" conspiracy.

The debate comes at a time when trust in medical institutions is already fragile. A 2025 survey by the Wellcome Trust found that nearly a third of UK adults had used alternative therapies in the past year, with younger demographics particularly drawn to "natural" remedies. The rise of social media has amplified the reach of figures like O’Neill, who blend wellness rhetoric with anti-establishment messaging to appeal to audiences disillusioned with mainstream healthcare.

For now, O’Neill’s UK tour is set to proceed, though some venues have faced pressure to cancel her events. In a statement posted on her website, she dismissed the criticism as "fearmongering by the medical-industrial complex," adding that her work "empowers people to take control of their own health."

The controversy highlights the challenges facing regulators and health authorities in an era where misinformation spreads faster than evidence-based advice. As the UK grapples with how to protect the public from harmful health claims, the case of Barbara O’Neill serves as a stark reminder of the stakes involved.

Air pollution’s hidden toll: UK study links emissions to disrupted sleep

A new UK-led study has shed light on a lesser-known consequence of air pollution: its impact on sleep quality. Researchers at the University of Cambridge found that increased exposure to fine particulate matter (PM2.5) and nitrogen dioxide (NO₂) is associated with higher rates of night-time coughing, which in turn disrupts sleep patterns. The findings, published in the European Respiratory Journal, suggest that even low-level exposure to air pollution can have measurable effects on daily health.

The study, led by Professor Cecilia Mascolo, used wearable devices to track the sleep and respiratory patterns of 1,200 participants across the UK over a 12-month period. The data revealed a clear correlation between spikes in air pollution and increased night-time coughing, particularly in urban areas. "Most research on air pollution focuses on severe outcomes like hospital admissions or premature death," Mascolo said. "But day-to-day symptoms, like coughing at night, are often overlooked, even though they can significantly affect quality of life."

The implications are far-reaching. Poor sleep is linked to a host of health issues, including cardiovascular disease, weakened immune function, and mental health disorders. The study’s authors noted that night-time coughing, while seemingly minor, can create a vicious cycle: disrupted sleep leads to fatigue, which in turn makes individuals more susceptible to respiratory infections. "It’s a hidden burden," Mascolo added. "People might not realise that their sleep problems are connected to the air they breathe."

The findings come as the UK faces renewed scrutiny over its air quality standards. While the country has made progress in reducing emissions since the 1990s, many urban areas still exceed World Health Organization (WHO) guidelines for PM2.5 and NO₂. A 2025 report by the UK Health Security Agency estimated that air pollution contributes to around 28,000 to 36,000 premature deaths annually, though the true toll may be higher when accounting for chronic conditions like sleep disruption.

Public health advocates have seized on the study as further evidence of the need for stricter air quality regulations. Clean Air London, an environmental campaign group, called the findings "a wake-up call" for policymakers. "We’ve known for years that air pollution damages our lungs and hearts, but this study shows it’s also stealing our sleep," said a spokesperson. "The government must act now to bring UK standards in line with WHO guidelines and protect public health."

The study also raises questions about how air pollution affects vulnerable groups, particularly children and the elderly. Previous research has shown that children exposed to high levels of air pollution are more likely to develop asthma and other respiratory conditions, which can further disrupt sleep. The Cambridge team is now planning a follow-up study to examine the long-term effects of air pollution on sleep quality in these groups.

For now, the findings serve as a reminder of the pervasive, if often invisible, impact of air pollution on daily life. As the UK debates its post-Brexit environmental policies, the study adds urgency to calls for stronger action to clean up the country’s air—and, in turn, its collective sleep.